Drug-labels.com

NRA-Domperidone: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
10 mg

Patient Medication Information: uses, side effects, how to take - NRA-Domperidone

ABOUT THIS MEDICATION

What the medication is used for:

NRA-DOMPERIDONE is used to treat symptoms of slowed stomach emptying seen in people with some gastrointestinal disorders (e.g. gastritis- inflammation of the GI tract). NRA-DOMPERIDONE is also used to reduce symptoms such as nausea and vomiting caused by some drugs used to treat Parkinson’s disease.

What it does:

NRA-DOMPERIDONE increases the mild digestive contractions of the esophagus and stomach and helps to more effectively coordinate the emptying of food from the stomach into the intestine. It also helps to more effectively move digesting food material through the small intestine.

When it should not be used:

It should not be used in patients who are known to be allergic to domperidone or any of the nonmedicinal ingredients (See What the nonmedicinal ingredients are). It should not be used in patients who show signs of bleeding in the stomach or intestines, or who may have an obstruction or perforation of the stomach or intestines.

It should not be used in patients who have a tumour associated with the pituitary gland known as a prolactinoma.

Do not use NRA-DOMPERIDONE if you have:

  • moderate or severe liver problems
  • heart disease including congestive heart failure or prolonged QT interval
  • prolactinemia (a pituitary tumour releasing prolactin)
  • electrolyte imbalance (unbalanced levels of salts) in your blood
  • are taking certain drugs listed in the Interactions section of this consumer information

What the medicinal ingredient is:

Domperidone Maleate

What the nonmedicinal ingredients are:

colloidal silicon dioxide, croscarmellose sodium, fumaric acid, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol and titanium dioxide.

What dosage forms it comes in:

NRA-DOMPERIDONE is available as 10 mg domperidone tablets (as domperidone maleate).

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

NRA-DOMPERIDONE may be associated with an increased risk of heart rhythm disorder and sudden death (cardiac arrest). This risk may be more likely in those over 60 years old or taking doses higher than 30 mg per day. Domperidone should be used at the lowest possible dose for the shortest duration necessary.

  • The maximum dosage is one 10 mg tablet three times daily, to help avoid adverse heart effects.
  • For patients at risk for heart problems, your doctor may request an assessment of your heart function (e.g. EEG) before and/or during domperidone treatment.

BEFORE you use NRA-DOMPERIDONE talk to your doctor or pharmacist if:

  • you have, or have ever had breast cancer
  • you have an irregular heartbeat, or any other kind of heart disease
  • you have any kind of kidney disease
  • you are pregnant of plan to become pregnant

  • you are breastfeeding or planning to breastfeed. Domperidone is excreted in breast milk. Discuss with your doctor.
  • you experience any kind of unusual discharge of breast milk
  • you are a male and have any kind of irregular growth of the breasts
  • you are taking any other medications (See Interactions with this medication)

INTERACTIONS WITH THIS MEDICATION

Do not take NRA-DOMPERIDONE with the following drugs as they are contraindicated:

  • antiarrhymics (drugs for the heart) including disopyramide, quinidine, hydroquinidine, amiodarone, dofetilide, dronedarone, sotalol)
  • certain antidepressants (e.g. citalopram, escitalopram)
  • certain antibiotics (e.g. erythromycin, clarithromycin, levofloxacin, moxifloxacin, spiramycin, telitromycin)
  • certain antifungal agents (e.g. pentamidine)
  • certain antimalarial agents (e.g. halofantrine, lumefantrine)
  • certain gastrointestinal agents (e.g. cisapride, dolasetron, prucalopride)
  • certain antihistamines (e.g. mequitazine, mizolastine)
  • certain cancer medicines (e.g. toremifene, vandetanib, vincamine)
  • some other medications (e.g. bepridil, methadone, diphemanil)
  • do not take NRA-DOMPERIDONE with grapefruit juice

Drugs that may interact with NRA-DOMPERIDONE include:

  • a drug called ketoconazole
  • any kind of drug known as:

    • an “anticholinergic” drug
    • an antifungal drug
    • an antibiotic drug
    • a drug to treat AIDS
    • a drug called nefazodone

PROPER USE OF THIS MEDICATION

Usual adult dose:

For disorders involving movement of food through the stomach and intestines: one 10 mg tablet taken 3 times per day, 15 to 30 minutes before meals.

Overdose:

Symptoms of overdosage may include drowsiness, disorientation, difficulty with normal body movements, irregular heartbeat and lowered blood pressure.

If you think you have taken too much NRA-DOMPERIDONE, contact your healthcare professional, hospital emergency department or regional poison control immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Most side effects will gradually disappear with continuing administration of NRA-DOMPERIDONE and are easily tolerated. The more serious or troublesome side effects are dose related and gradually resolve after the dose is lowered or if administration of the drug is discontinued.

Common side effects include dry mouth, headache and migraine. Uncommon side effects include abdominal cramps, diarrhea, regurgitation (bring up stomach contents), nausea and rash. If these side effects become troublesome, talk to your doctor.

Contact your doctor if more serious or troublesome side effects occur such as galactorrhea (excessive or spontaneous flow of breast milk), gynecomastia (excessive development of male mammary gland) or menstrual irregularities (spotting or delayed periods).

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Uncommonpalpitations√
irregular heart beat (arrhythmia)√
dizziness√
fainting√

This is not a complete list of side effects. For any unexpected effects while taking NRA-DOMPERIDONE, contact your doctor or pharmacist.

HOW TO STORE IT

Store between 15-30°C. Protect from light and moisture. Preserve in airtight container.

Keep out of the reach and sight of children.

MORE INFORMATION

If you want more information about NRA-DOMPERIDONE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for

    healthcare professionals and includes this Consumer Information by visiting the Health Canada website

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

(https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling 1-888-270-9874

Last Revised: October 10, 2025

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02561905

Revision date stated in the text: October 10, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NRA-Domperidone

Rx or OTC
Prescription (Rx)?
DIN 02561905
Schedule(s) PRESCRIPTION
Active ingredient(s) Domperidone (domperidone maleate) 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03F Propulsives
        1. A03FA Propulsives
          1. A03FA03 Domperidone
Company NORA PHARMA INC
Current status Marketed
Current status date April 21, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.